Improved Long-Term Survival for Rheumatic Mitral Valve Repair Compared to Replacement in the Young

World Journal for Pediatric and Congenital Heart Surgery

Volumn 4, Issue 2, 2013, Pages 155-164

  Remenyi, bo ^a   Webb, Rachel ^a   Gentles, Tom ^a   Russell, Peter ^b   Finucane, Kirsten ^a   Lee, Mildred ^a   Wilson, Nigel ^a  

^a STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

mitral valve; pediatrics; rheumatic heart disease; surgery; valvuloplasty

Indexed keywords

MITRAL VALVE; PEDIATRICS; RHEUMATIC HEART DISEASE; SURGERY; VALVULOPLASTY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MITRAL VALVE; MITRAL VALVE ANNULOPLASTY; NEW ZEALAND; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RHEUMATIC HEART DISEASE; SURVIVAL ANALYSIS; SURVIVAL RATE; SURVIVORS; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ARTICLE; ATRIAL FIBRILLATION; BACTERIAL ENDOCARDITIS; BIOPROSTHETIC VALVE REPLACEMENT; BLEEDING; CHILD; FEMALE; FOLLOW UP; HEART FAILURE; HEART VALVE BIOPROSTHESIS; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDTRONIC INTACT VALVE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; MORTALITY; MOSAIC BIOPROSTHESIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RHEUMATIC HEART DISEASE; RISK ASSESSMENT; SURVIVAL; THROMBOEMBOLISM; TRICUSPID VALVE REPAIR;

EID: 84885897926     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135112474024     Document Type: Article

References (34)

1. Carapetis JR Steer AC Mulholland EK Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005; 5(11):685–694.
2. World Bank. World Development Indicators database. http://databank.worldbank.org/ddp/home.do. Accessed 19 December, 2010.
3. Wilson N. Rheumatic heart disease in indigenous populations -New Zealand experience. Heart Lung Circ. 2010; 19(5-6):282–288.
4. Webb R Wilson N Lennon D. Population-based echocardiographic screening for rheumatic heart disease in high-risk New Zealand children. World Congress Paediatr Cardiol Card Surg. Cairns; 2009.
5. Shuhaiber J Anderson RJ. Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur J Cardiothorac Surg. 2007; 31(2):267–275.
6. Antunes MJ Magalhaes MP Colsen PR Kinsley RH. Valvuloplasty for rheumatic mitral valve disease. A surgical challenge. J Thorac Cardiovasc Surg. 1987; 94(1):44–56.
7. Pomerantzeff PM Brandao CM Faber CM, et al. Mitral valve repair in rheumatic patients. Heart Surg Forum. 2000; 3(4):273–276.
8. Deloche A Jebara VA Relland JY, et al. Valve repair with carpentier techniques. The second decade. J Thorac Cardiovasc Surg. 1990; 99(6):990–1001.
9. DiBardino DJ ElBardissi AW McClure RS Razo-Vasquez OA Kelly NE Cohn LH. Four decades of experience with mitral valve repair: analysis of differential indications, technical evolution, and long-term outcome. J Thorac Cardiovasc Surg. 2010; 139(1):76–83.
10. Akins CW Miller DC Turina MI, et al. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008; 135(4):732–738.
11. Gentles TL Colan SD Wilson NJ Biosa R Neutze JM. Left ventricular mechanics during and after acute rheumatic fever: contractile dysfunction is closely related to valve regurgitation. J Am Coll Cardiol. 2001; 37(1):201–207.
12. Jaffe WM Barratt-Boyes BG Sadri A Gavin JB Coverdale HA Neutze JM. Early follow-up of patients with the Medtronic Intact porcine valve. A new cardiac bioprosthesis. J Thorac Cardiovasc Surg. 1989; 98(2):181–192.
13. Jasinski MJ Kadziola Z Keal R Sosnowski AW. “Mosaic” medtronic bioprosthetic valve replacement clinical results and hemodynamical performance. J Cardiovasc Surg (Torino). 2000; 41(2):181–186.
14. Fradet G Bleese N Busse E, et al. The mosaic valve clinical performance at seven years: results from a multicenter prospective clinical trial. J Heart Valve Dis. 2004; 13(2):239–246.
15. Soper J Chan GT Skinner JR Spinetto HD Gentles TL. Management of oral anticoagulation in a population of children with cardiac disease using a computerised system to support decision-making. Cardiol Young. 2006; 16(3):256–260.
16. Gometza B al-Halees Z Shahid M Hatle LK Duran CM. Surgery for rheumatic mitral regurgitation in patients below twenty years of age. An analysis of failures. J Heart Valve Dis. 1996; 5(3):294–301.
17. Kalangos A Christenson JT Beghetti M Cikirikcioglu M Kamentsidis D Aggoun Y. Mitral valve repair for rheumatic valve disease in children: midterm results and impact of the use of a biodegradable mitral ring. Ann Thorac Surg. 2008; 86(1):161–168.
18. Talwar S Rajesh MR Subramanian A, et al. Mitral valve repair in children with rheumatic heart disease. J Thorac Cardiovasc Surg. 2005; 129(4):875–879.
19. National Heart Foundation of New Zealand. New Zealand guideline for prevention of infective endocarditis associated with dental and other medical interventions. 2008. http://www.heartfoundation.org.nz/index.asp?pageID=2145881467. Accessed 19 December, 2010.
20. Richey R Wray D Stokes T. Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ. 2008; 336(7647):770.
21. Wilson W Taubert KA Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American heart association rheumatic fever, endocarditis, and kawasaki disease committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation. 2007; 116(15):1736.
22. Gould FK Elliott TSJ Foweraker J, et al. Guidelines for the prevention of endocarditis: report of the working party of the British society for antimicrobial chemotherapy. J Antimicrob Chemother. 2006; 57(6):1035.
23. Wisenbaugh T Skudicky D Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation. 1994; 89(1):191–197.
24. Bonow RO Carabello BA Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2008; 118(15):e523–e661.
25. Antunes MJ. Mitral valvuloplasty, a better alternative. Comparative study between valve reconstruction and replacement for rheumatic mitral valve disease. Eur J Cardiothorac Surg. 1990; 4(5):257–262.
26. Chauvaud S Fuzellier JF Berrebi A Deloche A Fabiani JN Carpentier A. Long-term (29 years) results of reconstructive surgery in rheumatic mitral valve insufficiency. Circulation. 2001; 104(12 suppl 1): I12–I15.
27. John S Ravikumar E Jairaj PS Chowdhury U Krishnaswami S. Valve replacement in the young patient with rheumatic heart disease. Review of a twenty-year experience. J Thorac Cardiovasc Surg. 1990; 99(4):631–638.
28. Antunes MJ Vanderdonck KM Sussman MJ. Mechanical valve replacement in children and teenagers. Eur J Cardio-Thoracic Surg. 1989; 3(3):222–228.
29. Antunes MJ Colsen PR Kinsley RH. Mitral valvuloplasty: a learning curve. Circulation. 1983; 68(3 pt 2):II70–II75.
30. Alsoufi B Manlhiot C McCrindle BW, et al. Aortic and mitral valve replacement in children: is there any role for biologic and bioprosthetic substitutes? Eur J Cardio-Thoracic Surg. 2009; 36(1):84–90.
31. Travancas PR Dorigo AH Simoes LC Fonseca SC Bloch KV Herdy GV. Comparison of mechanical and biological prostheses when used to replace heart valves in children and adolescents with rheumatic fever. Cardiol Young. 2009; 19(2):192–197.
32. Sadler L McCowan L White H Stewart A Bracken M North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. BJOG. 2000; 107(2):245–253.
33. Walsh W Brown A Carapetis J. The diagnosis and management of chronic rheumatic heart disease -an Australian guideline. Heart Lung Circ. 2008; 17(4):271–289.
34. North RA Sadler L Stewart AW McCowan LM Kerr AR White HD. Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation. 1999; 99(20):2669–2676.